First Faculty of Medicine, Charles University, General University Hospital in Prague, Czech Republic
Michal Vrablík is a professor of internal medicine, Deputy Head of the 3rd Department of Internal Medicine at the First Faculty of Medicine, Charles University and General University Hospital in  Prague. His main areas of interest include preventive cardiology, clinical lipidology, and the genetics of lipoprotein metabolism disorders.
He is the President of the Czech Atherosclerosis Society, a board member of the Czech Society of Internal Medicine, and Vice-Chair of the Czech Association of Preventive Cardiology of the Czech Society of Cardiology. He leads the national centre for the FH MedPed screening program. In 2023, he was awarded a Fellowship of the European Federation of Internal Medicine, and in 2024, a Fellowship of the European Society of Cardiology. Since 2025, he has been a member of the Board of the Czech Medical Academy.
Between 2012 and 2016, Prof. Vrablík served as a board member of the European Atherosclerosis Society (EAS), and he continues to collaborate with the EAS as a member of its Educational and Award Committees. In 2018, he became a board member of the International Lipid Expert Panel. He closely collaborates with the International Atherosclerosis Society (IAS), where he has served as Chair of the IAS Regional Federation for Europe since January 2019.
Dr. Vrablík is the author or co-author of more than 400 papers in peer-reviewed scientific journals and serves on editorial boards and as a reviewer for several national and international journals.